New daily pill aims to shed pounds in obesity trial

NCT ID NCT07497880

Recruiting now Disease control Sponsor: Kailera Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 29, 2026 · Updated 6 times

Summary

This study tests an experimental oral medication, KAI-7535, taken once daily to help people with obesity or overweight lose weight. About 320 adults with at least one weight-related condition (like high blood pressure or sleep apnea) will receive either the drug or a placebo for 44 weeks. The main goal is to see how much body weight changes from the start of the study.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus Obesity obesity disorder Overweight type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OBESITY OVERWEIGHT

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

Kailera Clinical Site
RECRUITING

Chandler, Arizona, 85225, United States
Kailera Clinical Site
RECRUITING

Phoenix, Arizona, 85044, United States
Kailera Clinical Site
RECRUITING

Irvine, California, 92614, United States
Kailera Clinical Site
RECRUITING

Lincoln, California, 95648, United States
Kailera Clinical Site
RECRUITING

Northridge, California, 91325, United States
Kailera Clinical Site
RECRUITING

Hamden, Connecticut, 06517, United States
Kailera Clinical Site
RECRUITING

Jacksonville, Florida, 32256, United States
Kailera Clinical Site
RECRUITING

Jupiter, Florida, 33458, United States
Kailera Clinical Site
RECRUITING

Palm Springs, Florida, 33461, United States
Kailera Clinical Site
RECRUITING

Pembroke Pines, Florida, 33024, United States
Kailera Clinical Site
RECRUITING

Decatur, Georgia, 30030, United States
Kailera Clinical Site
RECRUITING

Chicago, Illinois, 60640, United States
Kailera Clinical Site
RECRUITING

Skokie, Illinois, 60077, United States
Kailera Clinical Site
RECRUITING

South Bend, Indiana, 46617, United States
Kailera Clinical Site
RECRUITING

Kenner, Louisiana, 70065, United States
Kailera Clinical Site
RECRUITING

Garden City, Michigan, 48135, United States
Kailera Clinical Site
RECRUITING

Jefferson City, Missouri, 65109, United States
Kailera Clinical Site
RECRUITING

Kansas City, Missouri, 64151, United States
Kailera Clinical Site
RECRUITING

Spartanburg, South Carolina, 29303, United States
Kailera Clinical Site
RECRUITING

Knoxville, Tennessee, 37909, United States
Kailera Clinical Site
RECRUITING

Austin, Texas, 78705, United States
Kailera Clinical Site
RECRUITING

Austin, Texas, 78757, United States
Kailera Clinical Site
RECRUITING

Brownsville, Texas, 78520, United States
Kailera Clinical Site
RECRUITING

Farmers Branch, Texas, 75234, United States
Kailera Clinical Site
RECRUITING

Fort Worth, Texas, 76135, United States
Kailera Clinical Site
RECRUITING

Mesquite, Texas, 75149, United States
Kailera Clinical Site
RECRUITING

San Antonio, Texas, 78222, United States
Kailera Clinical Site
RECRUITING

San Antonio, Texas, 78229, United States
Kailera Clinical Site
RECRUITING

San Antonio, Texas, 78240, United States
Kailera Clinical Site
RECRUITING

Sugar Land, Texas, 77479, United States
Kailera Clinical Site
RECRUITING

Sandy City, Utah, 84093, United States
Kailera Clinical Site
RECRUITING

Dee Why, New South Wales, 2100, Australia
Kailera Clinical Site
RECRUITING

Miranda, New South Wales, 2228, Australia
Kailera Clinical Site
RECRUITING

Wollongong, New South Wales, 2500, Australia
Kailera Clinical Site
RECRUITING

Norwood, South Australia, 5067, Australia
Kailera Clinical Site
RECRUITING

Altona N., Victoria, 3025, Australia

More trials for these conditions

Other studies related to the condition(s) this trial covers.